211 related articles for article (PubMed ID: 4610599)
1. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
[No Abstract] [Full Text] [Related]
2. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
Merrick EM; Schmitt PP
Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
[No Abstract] [Full Text] [Related]
4. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
Mindham RH; Gaind R; Anstee BH; Rimmer L
Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143
[No Abstract] [Full Text] [Related]
5. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
Freeman H; Mehta IS
Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
[No Abstract] [Full Text] [Related]
6. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
Stenson RL; Donion PT; Meyer JE
Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
[No Abstract] [Full Text] [Related]
7. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
Postma JU; Van Tilburg W
J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
[TBL] [Abstract][Full Text] [Related]
8. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
9. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
10. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
11. The antiparkinson properties of amantadine in drug-induced parkinsonism.
Kelly JT; Abuzzahab FS
J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353
[No Abstract] [Full Text] [Related]
12. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
13. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
Silver DE; Sahs AL
Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
[No Abstract] [Full Text] [Related]
14. Amantadine therapy in parkinsonism.
Forssman B; Kihlstrand S; Larsson LE
Acta Neurol Scand; 1972; 48(1):1-18. PubMed ID: 4553409
[No Abstract] [Full Text] [Related]
15. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
McEvoy JP; McCue M; Freter S
Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
[TBL] [Abstract][Full Text] [Related]
16. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
Iizuka J; Fischer R
Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
[No Abstract] [Full Text] [Related]
17. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
Appleton DB; Eadie MJ; Sutherland JM
Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
[No Abstract] [Full Text] [Related]
18. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
[No Abstract] [Full Text] [Related]
19. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
[No Abstract] [Full Text] [Related]
20. Effects of L-DOPA on pharmacological parkinsonism.
Bruno A; Bruno SC
Acta Psychiatr Scand; 1966; 42(3):264-71. PubMed ID: 5335155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
